NO170582C - Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelserInfo
- Publication number
- NO170582C NO170582C NO880667A NO880667A NO170582C NO 170582 C NO170582 C NO 170582C NO 880667 A NO880667 A NO 880667A NO 880667 A NO880667 A NO 880667A NO 170582 C NO170582 C NO 170582C
- Authority
- NO
- Norway
- Prior art keywords
- alkylenphenyl
- piperazinyl
- preparation
- heterocyclic compounds
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8700340 | 1987-02-17 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO880667D0 NO880667D0 (no) | 1988-02-16 |
| NO880667L NO880667L (no) | 1988-08-18 |
| NO170582B NO170582B (no) | 1992-07-27 |
| NO170582C true NO170582C (no) | 1992-11-04 |
Family
ID=22202287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO880667A NO170582C (no) | 1987-02-17 | 1988-02-16 | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0279598B1 (hu) |
| JP (1) | JPH0699405B2 (hu) |
| KR (1) | KR900004126B1 (hu) |
| CN (1) | CN1015627B (hu) |
| AP (1) | AP88A (hu) |
| AR (1) | AR245125A1 (hu) |
| AT (1) | ATE94537T1 (hu) |
| AU (1) | AU583761B2 (hu) |
| CA (1) | CA1312080C (hu) |
| CS (1) | CS272783B2 (hu) |
| DD (1) | DD272080A5 (hu) |
| DE (1) | DE3884007T2 (hu) |
| DK (1) | DK170878B1 (hu) |
| EG (1) | EG18635A (hu) |
| ES (1) | ES2058249T3 (hu) |
| FI (1) | FI91752C (hu) |
| HU (1) | HU207731B (hu) |
| IE (1) | IE61258B1 (hu) |
| IL (1) | IL85368A0 (hu) |
| IN (1) | IN171858B (hu) |
| MA (1) | MA21183A1 (hu) |
| MX (1) | MX174210B (hu) |
| MY (1) | MY103210A (hu) |
| NO (1) | NO170582C (hu) |
| NZ (1) | NZ223530A (hu) |
| PL (1) | PL157118B1 (hu) |
| PT (1) | PT86766B (hu) |
| SU (1) | SU1634136A3 (hu) |
| YU (1) | YU46624B (hu) |
| ZA (1) | ZA881064B (hu) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX173362B (es) * | 1987-03-02 | 1994-02-23 | Pfizer | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion |
| SE8803429D0 (sv) * | 1988-09-28 | 1988-09-28 | Pharmacia Ab | Novel pyridyl- and pyrimidyl derivatives |
| FR2655988B1 (fr) * | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5162321A (en) * | 1989-12-20 | 1992-11-10 | Adir Et Compagnie | 1-naphthyl piperazines useful as 5-HT1A receptor ligands |
| US5162324A (en) * | 1989-12-20 | 1992-11-10 | Adir Et Compagnie | Naphyl piperazines useful as 5-HT1A receptor ligands |
| US5166157A (en) * | 1989-12-20 | 1992-11-24 | Adir Et Compagnie | Naphthyl piperazines useful as 5-HT1A receptor ligands |
| US5166156A (en) * | 1989-12-20 | 1992-11-24 | Adir Et Compagnie | Naphthyl piperazines useful as 5-HT1A receptor ligands |
| ATE199147T1 (de) * | 1995-06-06 | 2001-02-15 | Aventis Pharma Inc | Benzisoxazol- und indazol- derivate als antipsychotika |
| GB9517381D0 (en) * | 1995-08-24 | 1995-10-25 | Pharmacia Spa | Aryl and heteroaryl piperazine derivatives |
| US6288091B1 (en) | 1995-12-29 | 2001-09-11 | Boehringer Ingelheim Ltd. | Antiherpes virus compounds and methods for their preparation and use |
| DE69624728T2 (de) * | 1995-12-29 | 2003-07-10 | Boehringer Ingelheim Pharma | Phenyl thiazol derivate mit antiherpesvirus eigenschaften |
| WO1999001420A1 (fr) | 1997-07-03 | 1999-01-14 | Taito Co., Ltd. | Procede de preparation de derives d'acide 2-aminomalonique, et intermediaires utilises dans ce procede |
| JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2927924A (en) * | 1958-04-03 | 1960-03-08 | Lilly Co Eli | Novel phenethyl-substituted piperazines |
| GB948766A (en) * | 1959-10-20 | 1964-02-05 | May & Baker Ltd | Trifluoromethylphenylpiperazine derivatives |
| DE1695410A1 (de) * | 1967-04-20 | 1971-04-08 | Merck Patent Gmbh | Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen |
| JPS5910675B2 (ja) * | 1976-03-22 | 1984-03-10 | ウェルファイド株式会社 | アラルキルアミン誘導体 |
| US4411901A (en) * | 1981-12-23 | 1983-10-25 | Mead Johnson & Company | Benzisothiazole and benzisoxazole piperazine derivatives |
| US4619930A (en) * | 1985-01-16 | 1986-10-28 | Bristol-Myers Company | Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use |
| JPH075579B2 (ja) * | 1986-09-01 | 1995-01-25 | 吉富製薬株式会社 | アミノチアゾ−ル化合物 |
-
1987
- 1987-02-17 MX MX010428A patent/MX174210B/es unknown
-
1988
- 1988-01-27 IN IN64/DEL/88A patent/IN171858B/en unknown
- 1988-02-09 IL IL85368A patent/IL85368A0/xx not_active IP Right Cessation
- 1988-02-12 EP EP88301171A patent/EP0279598B1/en not_active Expired - Lifetime
- 1988-02-12 AT AT88301171T patent/ATE94537T1/de not_active IP Right Cessation
- 1988-02-12 DE DE88301171T patent/DE3884007T2/de not_active Expired - Fee Related
- 1988-02-12 ES ES88301171T patent/ES2058249T3/es not_active Expired - Lifetime
- 1988-02-13 KR KR1019880001454A patent/KR900004126B1/ko not_active IP Right Cessation
- 1988-02-15 MA MA21420A patent/MA21183A1/fr unknown
- 1988-02-15 CN CN88100986A patent/CN1015627B/zh not_active Expired
- 1988-02-15 CA CA000558900A patent/CA1312080C/en not_active Expired - Fee Related
- 1988-02-15 JP JP63032593A patent/JPH0699405B2/ja not_active Expired - Fee Related
- 1988-02-15 PL PL1988270653A patent/PL157118B1/pl unknown
- 1988-02-15 PT PT86766A patent/PT86766B/pt not_active IP Right Cessation
- 1988-02-16 YU YU30388A patent/YU46624B/sh unknown
- 1988-02-16 AR AR88310090A patent/AR245125A1/es active
- 1988-02-16 AU AU11740/88A patent/AU583761B2/en not_active Ceased
- 1988-02-16 MY MYPI88000161A patent/MY103210A/en unknown
- 1988-02-16 AP APAP/P/1988/000082A patent/AP88A/en active
- 1988-02-16 ZA ZA881064A patent/ZA881064B/xx unknown
- 1988-02-16 NZ NZ223530A patent/NZ223530A/xx unknown
- 1988-02-16 SU SU4355194A patent/SU1634136A3/ru active
- 1988-02-16 DK DK078888A patent/DK170878B1/da not_active IP Right Cessation
- 1988-02-16 FI FI880716A patent/FI91752C/fi active IP Right Grant
- 1988-02-16 NO NO880667A patent/NO170582C/no not_active IP Right Cessation
- 1988-02-16 HU HU88748A patent/HU207731B/hu unknown
- 1988-02-16 DD DD88312959A patent/DD272080A5/de not_active IP Right Cessation
- 1988-02-16 CS CS96488A patent/CS272783B2/cs not_active IP Right Cessation
- 1988-02-16 IE IE42088A patent/IE61258B1/en not_active IP Right Cessation
- 1988-02-17 EG EG9388A patent/EG18635A/xx active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO168174C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser | |
| NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO171787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser | |
| NO871267L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
| NO170727C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyran-derivater | |
| NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
| NO172045C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer | |
| NO171913C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser | |
| NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
| NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO883485L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
| NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
| NO172539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser | |
| NO172489C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
| NO170582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser | |
| NO173185C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser | |
| NO173061C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner | |
| NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
| NO169007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater | |
| NO172802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner | |
| NO171501C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO168103C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater | |
| NO172115C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive bronkospasmolytiske forbindelser | |
| NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |